Learning the Sequence Determinants of Alternative Splicing from Millions of Random Sequences  by Rosenberg, Alexander B. et al.
Article
Learning the Sequence Determinants of Alternative
Splicing from Millions of Random SequencesGraphical AbstractHighlightsd Measured splicing patterns of nearly 2M synthetic
alternatively spliced mini-genes
d cis-regulatory elements primarily act additively rather than
cooperatively
d Model trained only on synthetic data predicts effects of
human SNPs on isoform ratios
d Model of alternative 50 and 30 splicing predicts effect of SNPs
in skipped exonsRosenberg et al., 2015, Cell 163, 698–711
October 22, 2015 ª2015 Elsevier Inc.
http://dx.doi.org/10.1016/j.cell.2015.09.054Authors
Alexander B. Rosenberg, Rupali P.
Patwardhan, Jay Shendure, Georg Seelig
Correspondence
gseelig@uw.edu
In Brief
A combination of synthetic biology and
machine learning approaches identifies
universal rules of RNA splicing and
enables the accurate prediction of the
effects of disease-related human SNPs
on isoform levels.Accession NumbersGSE74070
ArticleLearning the Sequence Determinants
of Alternative Splicing fromMillions
of Random Sequences
Alexander B. Rosenberg,1 Rupali P. Patwardhan,2 Jay Shendure,2 and Georg Seelig1,3,*
1Department of Electrical Engineering, University of Washington, Seattle, WA 98195, USA
2Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA
3Department of Computer Science and Engineering, University of Washington, Seattle, WA 98195, USA
*Correspondence: gseelig@uw.edu
http://dx.doi.org/10.1016/j.cell.2015.09.054SUMMARY
Most human transcripts are alternatively spliced,
and many disease-causing mutations affect RNA
splicing. Toward better modeling the sequence de-
terminants of alternative splicing, we measured the
splicing patterns of over two million (M) synthetic
mini-genes,which includedegenerate subsequences
totaling over 100 M bases of variation. The massive
size of these training data allowed us to improve
upon current models of splicing, as well as to gain
new mechanistic insights. Our results show that the
vast majority of hexamer sequence motifs measur-
ably influence splice site selection when positioned
within alternative exons, with multiple motifs acting
additively rather than cooperatively. Intriguingly,
motifs that enhance (suppress) exon inclusion in
alternative 50 splicing also enhance (suppress) exon
inclusion in alternative 30 or cassette exon splicing,
suggesting a universal mechanism for alternative
exon recognition. Finally, our empirically trained
models are highly predictive of the effects of naturally
occurring variants on alternative splicing in vivo.
INTRODUCTION
Alternative splicing is a major source of proteome diversity in eu-
karyotes (Nilsen and Graveley, 2010). Regulation of alternative
splicing is vital to cellular processes that depend on the precise
ratios of isoforms. For example, mutations that lead to even sub-
tle changes in the ratio of MAPT isoforms 3R and 4R cause an
inherited form of dementia (Garcia-Blanco et al., 2004). While
new sequencing technologies have enabled the comprehensive
cataloging of human genetic variation, the functional conse-
quences of these variants on even molecular phenotypes, such
as alternative splicing, remain poorly predictable.
Experimentally testing the consequence of every possible
genetic variant on endogenous alternative splicing is impractical,
motivating the development of predictive models of the ‘‘splicing
code.’’ The core splicing signals—50 splice donor, 30 splice
acceptor, branchpoint, and polypyrimidine tract—form the basis698 Cell 163, 698–711, October 22, 2015 ª2015 Elsevier Inc.of the splicing code; they are required for recognition of intron-
exon boundaries and for correct intron removal by the splicing
machinery. Computational methods have been developed to
score the likelihood of splicing at different splice donor and
acceptor sequences (Yeo and Burge, 2004). Splice regulatory
elements (SREs)—sequence motifs in exons or introns shown
to regulate splicing—form the next level of regulatory informa-
tion. SREs typically regulate alternative splicing by binding
trans-acting splice factor proteins (Ule et al., 2006; Wang et al.,
2013). Depending on their position and mode of action, SREs
are classified as exonic splice enhancers (ESEs), exonic splice
silencers (ESSs), intronic splice enhancers (ISEs), or intronic
splice silencers (ISSs). Examples of SREs have been identified
computationally by analyzing motif enrichment near splice sites
(Castle et al., 2008; Fairbrother et al., 2002; Zhang and Chasin,
2004) or sequence conservation between species (Goren et al.,
2006). Recently, a deep neural network was trained on exon
skipping events in the genome to generate a comprehensive
model of the splicing code that can be used to predict exon in-
clusion percentages (Xiong et al., 2014). Despite this progress,
current models of alternative splicing do not performwell enough
to be used in clinical genetics (e.g., to reclassify ‘‘variants of un-
certain significance’’), and many machine learning strategies
result in ‘‘black boxes’’ that limit mechanistic insight.
We hypothesized that a model of alternative splicing learned
from very large libraries of synthetic sequences could outper-
form models trained only on the genome. Current technology
makes it possible to create and test gene libraries with millions
of synthetic sequences—orders of magnitude more than the
number of alternative splice events in the human genome. In
other applications of machine learning, such as computer vision,
predictive power has increased greatly with access to larger
datasets (Le et al., 2012). Previous work supports the idea that
synthetic gene libraries with extensive and targeted variation
can provide mechanistic insight into biological phenomena.
In vivo (Culler et al., 2010; Wang et al., 2012) and in vitro (Yu
et al., 2008) randomized selections have identified potential
SREs. Massively parallel reporter assays (MPRAs) that combine
next-generation sequencing with extensive variation have been
applied to study transcription (Melnikov et al., 2012; Patwardhan
et al., 2012; Patwardhan et al., 2009; Sharon et al., 2012; Smith
et al., 2013; White et al., 2013), translation (Noderer et al., 2014),
mRNA stability (Oikonomou et al., 2014), and even alternative
AB
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Figure 1. A Predictive Model of Alternative
Splicing Learned from Millions of Synthetic
Sequences
(A) Two libraries with either alternative 50 or
30 splice sites were constructed with two 25-nt
randomized regions. The library was transfected
into human cells, and massively parallel mea-
surement of isoform ratios was performed with
RNA-seq. These two datasets were used to learn a
predictive model of alternative splicing. The model
takes a sequence as input, which is then con-
verted to 6-mer features. A score for each 6-mer is
learned and then used to predict the fractional
usage of each splice site.
(B) When human sequence variants are fed to
the model as inputs, the model makes more ac-
curate predictions than the current state of the art
algorithms.splicing (Ke et al., 2011). However, MPRA studies to date have
overwhelmingly focused onmeasuring the consequences of var-
iants in endogenous sequences (e.g., saturation mutagenesis) or
on validating predicted activities (e.g., enhancers predicted by
the ENCODE project). There are thus far few, if any, examples
of predictive biological models learned entirely on MPRA data.
To test whether it is possible to learn predictive biological
models from synthetic data alone, we developed an MPRA
that measures alternative splice site selection in a highly com-
plex library of ‘‘degenerate introns’’ (Figure 1A). We added
degenerate regions into an otherwise fixed sequence context,
ensuring that any differences in gene expression can be causally
attributed to the degenerate region. We created two libraries,
one with alternative 50 splice donors consisting of 265,137 mem-
bers and one with alternative 30 splice acceptors containing
2,211,739 members. We transfected these libraries to human
cells, performed RT-PCR and RNA sequencing (RNA-seq)
to quantitatively measure isoform ratio for all mini-genes and
used the results to learn a predictive model of alternative
splicing. To assess the quality of the resulting model, we pre-
dicted the effects of human sequence variants on isoform levels
and compared our results to available experimental data (Fig-
ure 1B). We tested variants in alternative 50 splicing events,
both within the alternative splice donors themselves and within
the alternative exon. Although our MPRA did not include a skip-
ped exon library, our model also predicted with high accuracy
the effect of sequence variants in skipped exons.
RESULTS
Molecular Phenotyping of Millions of Alternatively
Spliced Mini-Genes Containing Random Sequences
We chose to study both alternative 50 and alternative 30 splice
site selection. In the case of alternative 50 splicing, we first gener-Cell 163, 698–711,ated a complex library by introducing 23
25 nt fully degenerate regions into a sin-
gle-intron plasmid mini-gene (Figure 2A).
Specifically, the intron was designed
with two competing splice donors sepa-rated by 44 nt; one degenerate region was inserted between
the splice donors and the other downstream of the second
donor. Neither degenerate sequence overlapped a splice donor.
The mini-genes contained an additional degenerate 20 nt
barcode in the 30 UTR. This barcode was used to create a
look-up table linking barcodes and intronic sequences. Thus,
even when both degenerate regions were spliced out, their se-
quences could be recovered from the barcode sequence (Fig-
ure 2A). To maximize intron sequence variability, we constructed
and sequenced a complex library of 265,137 such mini-genes.
Thus, over 13 Mb of unique intronic sequence are represented
within the degenerate regions of this library (265,137 3 50 nt).
In the case of alternative 30 splicing, we inserted 2 3 25 nt
fully degenerate regions into a single-intron system designed
to have two alternative 30 splice sites (Figure 2C). The degen-
erate regions did not overlap either splice acceptor, but the
upstream degenerate region did overlap the typical position
of the first splice acceptor’s branchpoint (44:19 relative
to SA1). Similarly to the alternative 5
0 library, we included
an additional degenerate 20-nt barcode in the 30 UTR. The
alternative 30 library contained 2.2 million unique mini-genes
encompassing over 110 Mb of unique sequence variation
(2,211,739 3 50 nt).
We transfected the pooled libraries of plasmids into HEK293
cells and then quantified isoform ratios with targeted RNA-seq.
To identify both the isoform and originating plasmid of each
mRNA, we used paired-end sequencing with one read across
the exon junction and the other read across the 30 UTR barcode
(Figures 2A and 2C). We used 13 million reads for the alternative
50 library and 5.4 million reads for the alternative 30 library. We
were then able to calculate the isoform ratios for each mini-
gene in each library. We averaged 50.0 reads per mini-gene in
the 50 library with reads mapping to 265,044/265,137 (99.96%)
of all mini-genes. On the other hand, in the 30 library we averagedOctober 22, 2015 ª2015 Elsevier Inc. 699
only 2.47 reads per mini-gene with reads mapping to 1,686,096/
2,211,739 (76.23%) of all mini-genes.
Degenerate Sequences in Both Libraries Strongly
Influence Isoform Ratios
In the alternative 50 library, isoforms were present from several
different splicing events. The most upstream splice donor (SD1)
was used on average 22.4% of the time, while SD2 was used
50.0% of the time (Figure 2B). The remaining transcripts were
spliced at new splice donors inserted into the randomized
regions (11.3%), a cryptic splice donor site (SDCRYPT) 35 nt
downstream of SD2 (7.9%), or not spliced at all (8.4%). However,
as evidenced by the broad distributions of usage at each SD
(Figure 2B), the degenerate regions had a strong influence on
splice site selection. For instance, although 49.7% of mini-genes
spliced at SD1 with less than 5% frequency, 7,705 mini-genes
(2.9%) spliced at SD1 with over 95% frequency.
In the alternative 30 library, we also found isoforms from
different splicing events, although splice site usage was less
evenly balanced than in the 50 library. SA1 was used an average
of 3.3% of the time, while SA2 was used 89.2% of the time
(Figure 2D). In this library, new splice sites in the randomized re-
gions were only used with 0.3% frequency, probably reflecting
the larger information footprint of splice acceptors (>20 nt)
compared to splice donors (9 nt), which makes the occurrence
of new sites within the degenerate regions less likely. Similarly
to the 50 library, we inadvertently inserted a cryptic splice
acceptor 16 nt upstream of SA2 that was used with 4.6% fre-
quency. Many other cryptic splice sites were used with very
low frequency (1 3 107 to 5 3 103) accounting for a total of
2.3% of transcripts. In contrast with the alternative 50 library,
only 0.3% of transcripts were unspliced. Although SA2 was the
dominant splice site, 0.7% of the 1.2 M of mini-genes repre-
sented by multiple reads spliced 100% at SA1.
With so many transcripts in each library splicing at new splice
sites, we asked whether we could rediscover the known motifs
for splice donors and splice acceptors from the de novo sites
alone. When we plotted the relative frequencies of each base
at each position for new splice donors (Figure 2E) and new
splice acceptors (Figure 2F), both splice site motifs were nearly
identical to the expected motifs for splice donors and splice
acceptors. More specifically, the splice donors contained the ca-
nonical GT at the +1:+2 positions, while the splice acceptors
contain a clear polypyrimidine tract (T and C rich), followed by
N[CT]AGG. The ability to fully rediscover canonical signals for
splice donors and splice acceptors demonstrates the rich type
of information contained in each dataset.
We also asked whether translation might affect the mRNA sta-
bility in our libraries. Sequencing of the alternative 50 library
yielded fewer median reads on mRNA from mini-genes that
were primarily spliced out of frame than in frame (Figure S1A).
However, when the mini-genes contained a premature stop
codon, the median number of reads per mRNA was similar for
all three reading frames (Figure S1B). These results indicate
that a large string of amino acids translated out of frame will
destabilize the mRNA, likely through the no-go decay pathway
(Doma and Parker, 2006; Shoemaker et al., 2010) as ribo-
somes stall due to protein misfolding. We also find evidence of700 Cell 163, 698–711, October 22, 2015 ª2015 Elsevier Inc.nonsense-mediated decay, but only if the premature stop codon
occurred >40 nt upstream of the splice donor. This is consistent
with previous studies on nonsense-mediated decay that suggest
the premature stop codonmust occur >50 nt upstreamof the last
exon junction (Lewis et al., 2003).
Splicing Is More Likely to Occur at Upstream Splice
Donors
From an analysis of the new splice sites, we found strong evi-
dence that upstream splice donors were favored over down-
stream splice donors; new splice donors inserted in the first
degenerate region were 4.1 times more likely to be used than
new splice donors inserted into the second degenerate region
(region 1: 849,666 spliced reads; region 2: 208,396 spliced
reads). Furthermore, the effect of position of splice donors within
each degenerate region was significant (p < 0.005; Figure S1C).
The number of spliced reads at a new splice site decayed expo-
nentially with the distance from SD1 (Figure 2G). Splicing has
been shown to be co-transcriptional, and spliceosome compo-
nents can begin to assemble at a 50 splice donor before down-
stream alternative slice sites are transcribed (Listerman et al.,
2006), suggesting a potential mechanistic explanation for the
observed effect. This strong bias for upstream splice donors is
consistent with the typically short length of exons in the human
genome (Burge and Karlin, 1997).
Splicing Is Less Likely to Occur at Splice Acceptors with
Distal Branchpoints
Large-scale mapping of human branchpoints with RNA-seq
found that 90% of mapped branchpoints occur between 19–
37 nt upstream of the splice acceptor (Mercer et al., 2015). How-
ever, it remains unclear just how detrimental a distal branchpoint
is toward efficient splicing. Consensus branchpoints (CU[AG]A
[CU]) occur over 10,000 times at every position between 40 to
19 nt upstream of SA1 in our dataset, allowing us to answer this
question. We found that mini-genes with a consensus branch-
point sequence 19 nt upstream of SA1 were approximately six
times more likely to be spliced at SA1 relative to those with a
branchpoint 40 nt upstream of SA1 (Figure 2H). One explanation
for this phenomenon could be that distal branchpoints are more
likely to contain another AG between the branchpoint and SA1
that could be used as an alternative splice acceptor. However,
we observed a strong distance dependence on branchpoint po-
sition for sequences both with and without an AG between the
branchpoint and SA1 (Figure S1D). This result suggests that
mechanism by which distal branchpoints reduce splicing effi-
ciency is primarily due to the increased distance between the
branchpoint and the splice acceptor and/or polypyrimidine tract.
Sequence Motifs in Alternative Exons Have a Stronger
Regulatory Role than Intronic Sequences
Next, we asked how short sequence motifs affect splice site
selection in different contexts. We chose to analyze the effects
of 6-mer because each possible 6-mer occurs within an average
of 1,294 mini-genes for the alternative 50 library, and 8,232 mini-
genes for the alternative 30 library. Furthermore, most known
RNA binding proteins (RBPs) are reported to bind sequences be-
tween 4–8 nt (Lunde et al., 2007). In order to estimate the effect of
Figure 2. Splice Site Selection in Two Million Alternative 50 and 30 Spliced Sequences
(A) A schematic of the alternative 50 library. Spliced readsmap to SD1, SD2, and a cryptic splice site (SDCRYPT), as well as new splice donors (SDNEW) created in the
degenerate regions.
(B) Distributions of splice site usage across library mini-genes. Distributions are shown for SD1, SD2, SDCRYPT, and SDNEW. Insets correspond to the framed
regions in the main graph. Mean splice site usage is indicated with a blue vertical line.
(C) A schematic of the alternative 30 library. Spliced readsmap to SA1, SA2, and a cryptic splice site (SACRYPT), as well as new splice donors (SDNEW) created in the
degenerate regions.
(D) Distributions of splice site usage across library mini-genes. Distributions are shown for SD1, SD2, SDCRYPT, and SDNEW. Insets correspond to the framed
regions in the main graph. Mean splice site usage is indicated with a blue vertical line.
(E) The splice donor motif recovered from the new splice alternative 50 library matches the previously known human splice donor site.
(F) The splice acceptor motif recovered from the new splice alternative 50 library matches the previously known human splice acceptor site.
(legend continued on next page)
Cell 163, 698–711, October 22, 2015 ª2015 Elsevier Inc. 701
each possible 6-mer in each region, we calculated splice site us-
age for the subset of mini-genes containing the 6-mer and for the
much larger subset not containing the motif. We then asked to
what extent the odds of splicing at a splice site changed in the
presence of the motif relative to the control set. To quantify
this ‘‘effect size,’’ we used the log2 odds ratio with and without
the 6-mer present (Supplemental Experimental Procedures).
For example, we found that mini-genes containing the 6-mer
GTGGGG in the first degenerate region of the 50 library were
spliced at SD2 only 19.0% of the time, while RNA derived from
mini-genes not containing this motif spliced at SD2 50.2% of
the time, resulting in an effect size of 2.1 (Figures S2A–S2D).
In other words, the odds of splicing at SD2 are 4.29 (2
2.1) times
lower in the presence of GTGGGG compared to its absence.
In Figure 3A,weplot the empiricallymeasured effect sizes of all
hexamers in the first degenerate region on the relative usage of
SD2 and SD1, with 95% confidence intervals. The strongest en-
hancers located in the alternative exon (included when splicing
occurs at SD2, but excluded when splicing occurs at SD1)
increased the odds of splicing at SD2 4.38-fold, while the stron-
gest silencers decreased the odds 16-fold. Approximately 15%
of 6-mer have been previously identified as SREs (Culler et al.,
2010; Fairbrother et al., 2002; Wang et al., 2004, 2012) (622/
4,096), but here 82.9% of 6-mer (3,396/4,096) exhibited a signif-
icant effect on isoform selection (95% confidence interval does
not contain zero effect size). Intriguingly, the cumulative effects
of previously identified SREs accounted for only 20% of the cu-
mulative effects of all possible 6-mer. The strongest silencers
were G rich, consistent with known binding sites for hnRNPs
(Martinez-Contreras et al., 2006). On the other hand, some of
the strongest enhancers for SD2 appear to act by generating sec-
ondary structure aroundSD1: the6-merperfectly complementary
to part of SD1 (3 to +8) were all in the top 6% of SD2 enhancers
(percentiles: 97.77, 99.75, 99.97, 94.23, 94.79, and 98.92).
We then looked at the effects of 6-mers in the second degen-
erate region (30 to SD2). Unlike the first degenerate region, which
is located within the alternative exon region, the second degen-
erate region is intronic to both SD1 and SD2. We found that the
effect sizes weremuch smaller than in the first degenerate region
(Figure 3B). The strongest enhancer and silencer of SD2, respec-
tively, only changed the odds of splicing at SD2 relative to SD1
1.95-fold and 1.48-fold. Furthermore, only 36.7% of 6-mer
(1,505/4,096) had a statistically significant effect.
We performed a similar analysis for each degenerate region on
the usage of SA1 in the alternative 3
0 library (Figures 3C and 3D).
Again, we found that motifs in the alternative exon (30 of SA1, but
50 of SA2) had strong effect sizes (statistically significant 6-mer
effect sizes: 3,500/4,096, 85.4%; strongest enhancer: 3.84-fold
increase in odds of splicing at SD2; strongest silencer: 9.87-
fold decrease in odds of splicing at SD2). Unlike in the alternative
50 library, we found that motifs in the intronic degenerate region(G) The number of spliced reads at each position within the randomized region
upstream (50) splice donor than at a downstream (30) splice donor. The gray line is
the log read count at that location.
(H) Mini-genes with a consensus branchpoint near SA1 are much more likely to us
usage, when there is no consensus branchpoint.
See also Figure S1.
702 Cell 163, 698–711, October 22, 2015 ª2015 Elsevier Inc.(50 of SA1 and SA2) also had quite strong effects (statistically
significant 6-mer effect sizes: 3,248/4,096, 79.3%; strongest
enhancer: 3.45-fold increase in odds-ratio; strongest silencer:
4.63-fold decrease in odds-ratio), although still generally smaller
in magnitude than the downstream alternative exon region.
When we looked at the strongest 6-mer enhancers of SA1 in
this intronic region, we found they all fit the consensus branch-
point sequence CU[AG]A[CU] (Figure 3D).
The Same Sequence Motifs Regulate Alternative Exon
Inclusion Independent of the Type of Alternative
Splicing
Surprisingly, we found that the effect sizes of 6-mers occurring
within the alternative exon regions were extremely similar be-
tween the alternative 50 and 30 libraries (Figure 3E; R2 = 0.68).
We looked at several motifs known to bind splice factors or
that have previously been identified as ESEs/ESSs (G-run,
SRSF1, hnRNPA1, hnRNPH2) and found the effect sizes to be
highly correlated. In both libraries, GGGGGG was the strongest
exonic silencer (50 library: 16.0-fold change in odds ratio; 30 li-
brary: 9.87-fold reduction in odds ratio).
We also compared the effect sizes of intronic 6-mers (second
randomized region in the alt. 5 library; first randomized region in
the alt. 30 library) between the two libraries. We found a signifi-
cant, but weaker, correlation between the 6-mer scores (R2 =
0.27; Figure S2E). The first randomized region in the alternative
30 library overlaps the expected location of the SA1 branchpoint,
which may reduce the effect size correlation. However, the
weaker correlation can also be explained by the fact that the
effect sizes of intronic 6-mer were much smaller in magnitude
compared to 6-mer within the alternative exon regions.
Sequence Motifs Regulate Exon Inclusion Additively
Rather than Cooperatively
Although previous studies have observed co-occurrence of
conserved sequence motifs around splice sites (Barash et al.,
2010), it remains unclear whether such motifs act cooperatively
or additively and independently of one another to regulate alter-
native splicing. In an additive and independent model of regula-
tion, the joint effect size of multiple motifs should simply equal
the sum of the individual effect sizes (Figure 4A). To assess
this, we examined the joint effect sizes of pairs of 4-mers on
alternative exon-inclusion levels in both the 50 and 30 libraries.
We chose 4-mers because pairs of 4-mers occur sufficiently
often within each randomized region to allow for robust effect
size measurements (alt. 50 library: 692 mini-genes/4-mer pair;
alt. 50 library: 4,399 mini-genes/4-mer pair).
We first calculated the individual effect size of all 4-mers on
exon inclusion in the 50 library. We then calculated the joint effect
size of every possible pair of non-overlapping 4-mers. Surpris-
ingly, we found that combinatorial effects were extremely wells shows a strong position dependency. Splicing is more likely to occur at an
a fit that shows the linear relationship between the location of splice donor and
e SA1 than mini-genes with a distal branchpoint. The red line indicates the SA1
Figure 3. Measured Effect Sizes of Individual 6-mer in Each Degenerate Region
(A–D) Tomeasure how sequencemotifs alter the relative use of SD2/SD1 or SA1/SA2, we calculated effect sizes for every 6-mer (n = 4,096) within each degenerate
region in both libraries. We defined effect sizes as the log odds ratio of SD2 or SA1 usage between mini-genes with/without the 6-mer of interest. The 6-mer are
ranked by estimated effect size and plotted with 95% confidence intervals generated by bootstrapping with replacement. (A) Alternative exon region in 50 library.
(B) Intronic region in 50 library. (C) Alternative exon region in 30 library. (D) Intronic region in 30 library.
(E) The 6-mer scores in the alternative exon region in both the 50 and 30 libraries (A and C) are highly similar, suggesting alternative splicing in both libraries is
regulated by the same mechanism.
See also Figure S2.
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Figure 4. Combinatorial Regulation of
Alternative Splicing Is Additive
(A) An additive model of alternative splicing regu-
lation: the joint effect size of two 4-mer is equal to
the sum of the individual 4-mer effects.
(B) Using an additive model, the predicted
combinatorial effect size of every pair of 4-mer (n =
65,536) is plotted on the left. Each pixel corre-
sponds to a pair of 4-mer with the 50 4-mer on the
x axis and the 30 4-mer on the y axis. The
measured combinatorial effect sizes from the 50
library data are plotted in the middle. The residuals
between the additive model and the observed
data are plotted on the right. The additive model
explains >90% of the combinatorial effect sizes
(R2 = 0.913).
(C) The same analysis is repeated for the alterna-
tive 30 library. In this library the additive model
explains over 95% of the combinatorial effect
sizes (R2 = 0.954).
See also Figure S3.captured by the sum of the 4-mer’s individual effect sizes (R2 =
0.913; Figure 4B). We did the same analysis for 4-mers located
in the second degenerate region of the 30 library. Here, the linear
model fit the experimental data even better (R2 = 0.954; Fig-
ure 4C). Thus, while specific instances of cooperative sequence
interactions have been well documented (Huelga et al., 2012;
Oberstrass et al., 2005), our results suggest themajority of motifs
primarily exert their influence on exon inclusion independently of
the surrounding motifs.
Predicting Isoform Ratios in Alternative Splicing from
Sequence Information
We then turned to the task of learning a model of alternative
splicing to predict isoform levels from sequence information.
Becausecombinatorial regulationofalternativesplicingwasaccu-
rately captured by an additive model, we postulated that an addi-
tive model with short sequences as input features would perform704 Cell 163, 698–711, October 22, 2015 ª2015 Elsevier Inc.well for prediction. Using both the 50 and 30
libraries, we trained a joint model of alter-
native exon definition in which a score is
learned for each of the 4,096 possible 6-
mers (Figure S3A). The scores learned
here are similar to the previously calcu-
lated effect sizes, but rather than
measuring the effects of a single 6-mer
one at a time, we learned all the scores
together through regression. Given the
large number of new splice donors ap-
pearing within the 50 library, we also chose
to train a model of the splice donor site
itself (Figure S3B). When we tested the
splice donor model using cross validation,
we found it accurately predicted the frac-
tion of reads mapping to the three original
splice donors, accounting for up to 75%of
observed isoform variability (R2: SD1 =
0.75, SD2 = 0.75, SDCRYPT = 0.54; Fig-ure 5A). It also proved accurate in predicting the position and
fraction of reads mapping to newly created splice donor sites
within the degenerate regions (R2: 0.83; Figures 5A and 5B).
A fundamental advantage of testing synthetic sequences is the
ability to learn from larger datasets thanwere previously available.
As an attempt to quantify this advantage, we calculated learning
curvesonasimplemodel predictingusageofSD1 in thealternative
50 library. We split our data into training and test sets (90%/10%
split) and trained models using subsets of the training data (be-
tween 100 to 177,827 training points). We also trained separate
models using 3-mers, 4-mers, 5-mers, 6-mers, or 7-mers. With
limited data (1,000 or fewer training points), the simplest model
(3-mers) made the most accurate predictions, while the 7-mer
model made the least accurate predictions, with the other models
ordering between (Figure 5C). However, with the largest training
subset (177,827 points), the results were reversed with the 7-mer
model achieving the highest accuracy. Based on the slopes of
(legend on next page)
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the learning curves, the 3-mer to 5-mer models would not benefit
significantly frommore data points (> 177,827), but the 6-mer, and
especially the 7-mer, models seem likely to achieve significantly
higher prediction accuracy with larger training sets. These results
highlight the intuitive point that richer feature sets can improve
predictions accuracy, but require more data to properly train.
Predicting the Effects of Human Genomic SNPs on
Alternative Isoform Ratios
Next, we asked whether we could apply our model (HAL [hex-
amer additive linear])—developed entirely in the context of
synthetic mini-genes—to predict changes in alternative splice
donor usage caused by common polymorphisms in human
genomes. As a first test case, we focused on 50 alternative
splicing. Combining DNA and RNA sequencing data, respec-
tively, from the 1000 Genomes Project (Abecasis et al., 2012)
and GEUVADIS consortium (Lappalainen et al., 2013), we calcu-
lated the percent of splicing at the downstream alternative splice
donor (percent spliced in [PSI]) of wild-type genotypes for 8,546
50 alternative splicing events using the MISO software package
(Katz et al., 2010). We separately calculated mean isoform levels
for genotypes heterozygous or homozygous for a single SNP in
the region between the two competing splice donors or within
the splice donors themselves (Table S1).
We began by investigating whether the model of the actual 9-
nt splice donor sequence—again learned completely from our
synthetic mini-genes—could accurately predict the effects
of SNPs occurring within splice donor sequences. We also
compared our prediction accuracy to a leading splice donor pre-
diction tool trained directly from splice donor usage in the human
genome (MaxEnt) (Yeo and Burge, 2004). Among heterozygous
SNPs in alternative splice donors occurring in multiple individ-
uals, we found that 93 of 199 SNPs altered PSI by >5% (Figures
6A and 6B). Within this set, HAL predicted the direction of
change with 87.1% accuracy (81/93; binomial p = 9.83 3
1014), while MaxEnt predicted the direction of change with
81.7% accuracy (76/93; binomial p = 4.45 3 1010). Among
the 35 homozygous SNPs in splice donors that alter PSI
by >5%, our model predicted every SNP correctly, while MaxEnt
made two mistakes (HAL: 35/35, binomial p = 5.82 3 1014;
MaxEnt: 33/35, binomial p = 3.67 3 1010). For the set of
SNPs within splice donors, our model explained 59.3% of the
observed heterozygous effects (R2 = 0.593, p = 6.38 3 108)
and 67.7% of the observed homozygous effects (R2 = 0.677,
p = 4.65 3 1024). This is a substantial improvement over Max-
Ent, which accounted for 39.8% of the observed heterozygous
effects (R2 = 0.398, p = 1.223 1011) and 41.1% of the observed
homozygous effects (R2 = 0.411, p = 3.33 105). Even when weFigure 5. A Model Accurately Predicts Alternative 50 Splicing and the L
(A) For each splice donor (SD1, SD2, SDCRYPT), model predictions are plotted aga
plasmid. The results are also plotted for all new splice sites (SDNEW).
(B) The prediction results for three different mini-genes are shown with the associa
averaging the model weights of all 6-mer overlapping the nucleotide. In the first e
which is confirmed by RNA-seq.
(C) A learning curve was generated for different models that predict the fraction o
small training sets (<1,000 data points), but with more data points, richer feature
See also Figure S5.
706 Cell 163, 698–711, October 22, 2015 ª2015 Elsevier Inc.extended our analysis to all SNPs (including those with less than
5% change in PSI), we found HAL substantially outperformed
MaxEnt (HAL: R2 = 0.48; MaxEnt: R2 = 0.22; Figure S4A).
We then applied the model to predict the effects of human
genomic SNPs in the alternative exon region between, but not
overlapping, splice donors. Because most SNPs not occurring
in actual splice sites are likely to only have modest effects, we
restricted our analysis to SNPs with at least ten homozygous
wild-type or ten heterozygous samples expressing the relevant
mRNA. Moreover, we focused on SNPs that resulted in a change
in the PSI of at least 5% to minimize the impact of measurement
noise on the validation dataset; 43/344 heterozygous and 20/
131 homozygous SNPs altered the PSI by >5% (Figure 6C). HAL
correctly predicted thedirectionof change for 37/43heterozygous
and 17/20 homozygous SNPs (p: heterozygous = 1.63 3 106,
homozygous = 2.58 3 103, combined = 6.11 3 109). Further-
more, our model explained around half of the total observed
effects of these SNPs (heterozygous: R2 = 0.570, p = 9.23 3
109; homozygous: R2 = 0.442, p = 1.393 103). Thus, our model
not only outperformed the state of the art splice donor algorithm
(MaxEnt) at predicting the effects of SNPs within splice donors
but alsosuccessfullypredicted theeffectsofSNPswithin thealter-
native exon region, which to our knowledge, no other tool can do.
Predicting Alternative 50 Isoform Levels from Sequence
Information
To further assess the accuracy of our splice donor model, we
predicted the isoform ratios in 6,152 alternative 50 splicing events
expressed in lymphoblastoid cell lines and compared our results
to four other splice donor prediction algorithms. Our splice donor
model substantially outperformed all of the other algorithms (Fig-
ure S5; Table S2). Interestingly, all of the models (including ours)
performed better on events with shorter alternative exon regions
(i.e., the region between splice donors). In these events, there is
less space for regulation between the splice donors, possibly
simplifying the prediction task.
Predicting the Effects of Variants on Exon Skipping in
Mendelian Diseases
The most common form of alternative splicing is neither alter-
native 50 or 30 splicing, but exon skipping. Exon skipping is
a highly regulated form of alternative splicing in human cells,
and misregulation of cassette exon splicing can cause disease
(Garcia-Blanco et al., 2004) and cancer (Kim et al., 2008). Given
the relatively more complex structure of skipped exons, it might
on first sight seem unlikely that a model trained only on 50and 30
alternative splicing should be able to predict levels of exon
inclusion. However, we hypothesized that the similarity betweenocation of New Splice Donors
inst the observed splice site usage fraction. Each point represents a single test
ted nucleotide scores for each isoform. Each nucleotide score is calculated by
xample mini-gene, HAL predicts the usage and position of a new splice donor,
f splicing at SD1. The simplest model (3-mer features) performed the best with
sets offer better performance.
Figure 6. Splicing Model Identifies the
Functional Effect of SNPs on Alternative
Splicing
(A–C) Model predictions are plotted with the PSI
measured fromRNA-seq for SNPs occurring in the
upstream splice donor (A), the downstream splice
donor (B), and between the competing splice
donors (C) that alter the measured PSI by greater
than 5%. The observed PSI from RNA-seq for the
wild-type genotype (gray bar) and genotypes
containing the SNP (red) are plotted together with
the model prediction (blue). The model accurately
predicts the direction of change of the heterozy-
gous SNPs in splice donors with 87.1% accuracy
(81/93; binomial p = 9.83 3 1014) and the het-
erozygous SNPs between splice donors with
86.0% accuracy (37/43; binomial p = 8.183 107).
See also Figure S4 and Tables S1 and S2.the sequence determinants of alternative exons in alternative 50
and 30 splicing might extend to exon skipping as well. If this
were the case, we would expect our model to accurately predict
the effects of exonic sequence variants on skipped exon-inclu-
sion levels, even though it was never trained directly on any
exon skipping data. We tested this hypothesis in the context of
mutations in several distinct genes that are known to causeMen-
delian disease by promoting exon skipping (Figure 7A; Table S3).
First, we compared model predictions to experimental data for
theSMN1 andSMN2 genes, whosemisregulation can lead to spi-Cell 163, 698–711,nal muscular atrophy. Our model correctly
predicted increased or decreased exon
7 inclusion in 205/229 (89.5%; Figure 7D)
variants with experimental data. In
Figure 7B, we compare predictions
(increased or decreased exon inclusion)
to experimental data. To make the plot
more readable, we only included a single
SNP at each position. Our model accu-
rately predicts increased/decreased
exon inclusion for 20/22 of the plotted
SNPs. On just the variants with quantita-
tive data (n = 131), our model explained
65% of the observed variance (R2 =
0.65; Figure 7E). The SMN1/2 variants
that we tested included SNPs, indels,
and combinations of up to 30 nt changes.
We then tested our model on variants
in CFTR, whose misregulation can lead
to cystic fibrosis. Our model correctly
predicted increased/decreased exon
12 inclusion in 19/22 variants (Figure 7D).
When we only looked at the SNP with
the largest effect at each position, our
model accurately predicted increased/
decreased exon inclusion for 11/12
SNPs (Figure 7C). Among all the CFTR
variants, our model explained 60% of the
observed variance (Figure 7E; R2 = 0.60).Next, we tested our model predictions on variants in exon 7 of
the BRCA2 gene, a tumor suppressor responsible for DNA dam-
age repair. Mutations in BRCA2 affecting the ability of the pro-
tein to repair DNA lead to such an increased risk of ovarian and
breast cancer that patients with these mutations may choose to
have prophylactic surgery. However, the effect of many variants
on alternative splicing and hence protein function remain un-
known, forcing patients and doctors to make clinical decisions
with limited information. The ability to identify deleterious
variants computationally can provide valuable information toOctober 22, 2015 ª2015 Elsevier Inc. 707
Figure 7. Predicting the Effects of Exonic
Variants on Exon Skipping
(A) The inputs to the splicing model can include
SNPs, indels, or complex variants within the alter-
native exon. The splicing model then predicts the
exon inclusion levels with the variant present.
(B) Model predictions are compared to experi-
mental results using RT-PCR for SNPs occurring
in exon 7 of SMN2. For positions with data for
multiple SNPs, the SNP with the largest measured
change in PSI was plotted. The model accurately
predicted the directional change in PSI (increased
exon inclusion/exclusion) for 20/22 SNPs plotted.
(C) Model predictions are compared to experi-
mental results using RT-PCR for SNPs occurring
in exon 12 of CFTR. The model accurately pre-
dicted the directional change in PSI for 11/12
SNPs plotted.
(D) The prediction accuracy for variants in SMN2,
CFTR, and BRCA2 ranged from 86% to 90%.
(E) The change in PSI is plotted for every variant
with RT-PCR data. The model explains over 60%
of the effects of SNPs for variants each gene
tested (SMN1/2, CFTR, and BRCA2).
See also Figure S6 and Table S3.patients with these variants of unknown significance. Our model
correctly predicted increased/decreased exon 7 inclusion for
31/35 variants that experimentally altered inclusion levels (Fig-
ure 7D). The model correctly predicted 19/22 of the SNPs with
the largest effect at each position within the exon (Figure S6B).
Among all the BRCA2 variants, our model explained 67% of the
observed variance (R2 = 0.67; Figure 7E).
We then compared our results to SPANR (Xiong et al.,
2014)—the current state of the art in predicting the effects of
SNPs on exon skipping. SPANR consists of a Bayesian deep
learning algorithm trained on exon skipping events in the
human genome with 1,393 carefully hand-selected features.
As of this paper, SPANR only supports predictions of SNPs,
so we were not able to compare our predictions on more com-
plex variants. However, for SNPS in SMN1/2, CFTR, and
BRCA2, we found that HAL accounted for three times more
of the observed effects than SPANR (HAL: R2 = 0.51; SPANR:
R2 = 0.17; Figure S6A). We made HAL publicly available
at http://splicing.cs.washington.edu. All of the code to repro-
duce this study is publicly available at https://github.com/
Alex-Rosenberg/cell-2015.
DISCUSSION
We present a framework based on massively parallel analysis of
synthetic sequences to dramatically improve our understanding708 Cell 163, 698–711, October 22, 2015 ª2015 Elsevier Inc.of alternative splicing and the ability to
predict the impact of natural human
genetic variation. Our model accurately
predicts the effects of sequence vari-
ants on alternative 50 splicing that occur
both within the alternative exon and in
the competing splice donors. Even moreimportantly, our model learned regulatory rules about alterna-
tive splicing that generalized to exon skipping—a completely
different form of alternative splicing than those on which the
model was trained.
Our results suggest that a common regulatory mechanism is
shared between all major forms of alternative splicing. Additional
evidence for such a common mode of regulation comes from
previous smaller-scale studies of ESEs or ESSs that have shown
similar effects across different forms of alternative splicing
(Wang et al., 2006, 2012). It is unlikely that this shared form of
regulation occurs during splice site recognition; any exonic
splice regulatory element that alters splice donor or splice
acceptor recognition should have different effects in alternative
50 and 30 splicing events. It is more likely that alternative exon in-
clusion is modulated during exon definition, that is the pairing of
splice site across exons, which often precedes the eventual pair-
ing of splice donors and acceptors across introns (Robberson
et al., 1990).
Furthermore, our data also suggest that the exon-defining inter-
actions between the upstream splice acceptor and downstream
splice donor are regulated additively. In both alternative 50 and 30
splicing,we found the joint effect sizeofmultiple4-mer tobehighly
correlated with the sum of the individual 4-mer effects. This result
may indicate that eachsequencemotif cancontributeadditively to
stabilizing the splice acceptor-splice donor interaction, likely
through the trans-factors that bind these sites. However, the true
mechanistic basis for this additivity will require further investiga-
tion. Although, there is evidence supporting specific examples of
functional interactions between cis-splicing regulatory elements
(Oberstrass et al., 2005), our results indicate that these examples
are likely uncommon.
A potential limitation of our approach is that mRNAs are tran-
scribed from plasmids rather than directly from the genome,
especially considering evidence suggesting that chromatin
can influence alternative splicing (Luco et al., 2010). However,
advances in high-throughput genome editing may make it
possible to perturb the genome in a massively parallel fashion,
whichwill enable extensions of our approach to probe the effects
of chromatin on alternative splicing. In fact, recent work demon-
strated that small-scale genomic libraries could be created
through insertion of degenerate sequences directly into an alter-
natively spliced gene locus (Findlay et al., 2014). Moreover, our
current work focused onmini-genes with short alternative exons,
and more work will be necessary to understand to which extent
our results generalize to other gene architectures. However,
human exons are typically short (an average 147 bp for internal
exons) (IHGSC et al., 2001), and,moreover, analysis of sequence
conservation suggests that most sequence determinants of
alternative splicing can be found within a few hundred nucleo-
tides of intron-exon junctions. It is important to emphasize that
our approach uncovers only cis-regulatory rules. Complemen-
tary experiments that connect this cis-grammar to a repertoire
of trans-acting splice factor proteins are necessary to fully un-
derstand themechanisms underlying the regulation of alternative
splicing.
We have demonstrated that learning the sequence determi-
nants of gene regulation from large libraries of synthetic se-
quences can be used as a complementary approach to learning
directly from the human genome. We assayed over two million
alternatively spliced constructs, nearly two orders of magnitude
more events than the 38,000 that are present in the human
genome (Wang et al., 2008), containing over 100 Mb of synthetic
sequence. Our improved understanding of alternative splicing
and performance in predicting the effects of genetic variants
is not a result of more sophisticated machine learning algorithms
but simply the result of learning from a larger and more reliable
dataset. We anticipate that this general approach will be
useful for advancing our biological understanding of diverse
forms of gene regulation, such as transcription, translation,
and polyadenylation.
EXPERIMENTAL PROCEDURES
Cloning of Degenerate Libraries
The libraries were assembled with PCR and standard Gibson assembly
(Gibson et al., 2009) using degenerate oligonucleotides (IDTDNA). First Citrine
was split into two exons, and the first exon of the Citrine gene was altered to
remove any potential splice donors, without altering the amino acid sequence.
The introns with degenerate sequences were inserted between the two exons
of Citrine. The barcode sequence was inserted into the 30 UTR of Citrine.
Cell Culture and Transfection
HEK293 cells were cultured in in DMEM (Cellgro) plus 10% FBS and L-gluta-
mine/penicillin/streptomycin on coated plates. Plates were coated for 24 hr
with 8 ml of 1003 diluted extracellular matrix gel (Sigma-Aldrich) before
HEK293 cells were added to the plates. For transfection of a complex poolof plasmids, 1.2 million cells were seeded in a 10-cm dish 24 hr before trans-
fection. We mixed 10 mg of the plasmid library in 1 ml of Opti-MEM Reduced
Serum Medium (Life Technologies) with 30 ml of Lipofectamine LTX and
10 ml of Plus Reagent (Life Technologies), before transfecting into the 10-cm
dish. The DMEM was replaced 5 hr after transfection.
Isolation of RNA and Generation of cDNA
Total RNA was extracted using RNeasy (QIAGEN) kits 24 hr after transfection.
The optional on column DNaseI digest was performed with the RNase-Free
DNase Set (QIAGEN). Total RNA quality and purity was tested by measuring
the A260/A280 ratio on a NanoDrop 1000 Spectrophotometer and, in some
cases, by measuring the ratio of the 18S and 28S rRNA bands on a native
1% agarose gel. mRNA was separated from 35–48 mg total RNA using polyA
Spin mRNA Isolation Kits (New England Biolabs). Isolated mRNA was again
digested by DNaseI for 30 min using the Turbo DNA-free Kit (Ambion). cDNA
was then synthesized from 109–374 ngmRNA usingMultiScribe Reverse Tran-
scriptase (Ambion) and Oligo d(T)16 primers (Ambion). cDNA synthesis was
performed by holding reactions at 25C for 10 min, 42C for 110 min, and
85C for 5 min. The quality of cDNA and presence of DNA contamination
were checked through qPCR:Citrine,mCherry, and TBPwere compared using
cDNA, no reverse transcription controls (NRTC), and a no template control
(NTC). The results indicated that there was no plasmid or genomic DNA carry-
over into the cDNA reactions.
Generation of Illumina FlowCell Compatible PCRProducts fromRNA
and DNA Library
The resultant cDNA was then amplified by PCR to generate products compat-
ible with the Illumina HiSeq2000 Flow Cell. PCR reactions were performed in
100 ml with 2x Phusion HFMaster Mix (New England Biolabs), 50 pmol forward
primer, and 50 pmol reverse primer with sample specific barcodes and 20% of
each cDNA reaction. Cycling was done on a BioRad T100 Thermal Cycler with
the following protocol: 98C for 5 min, then seven cycles of 98C for 10 s,
67.5C for 15 s, 72C for 30 s, and a final extension step at 72C for 5 min.
The necessary number of cycles was determined for each sample by first
running qPCR reactions with EvaGreen in a Biorad CFX and determining
when fluorescence began to plateau. Following PCR, 10% of the products
were run on a 2% agarose gel to determine if the expected bands were pre-
sent. The remainder of the PCR products was purified using the QIAquick
PCR Purification Kit (QIAGEN) and eluted into 30 ml of EB. Concentrations,
as well as A260/280 and A260/230 ratios, were measured on a NanoDrop
1000 Spectrophotometer.
Illumina-compatible PCR products were also generated from the DNA
plasmid library with the same protocol as above, except the cDNA template
was replaced with 10 ng of plasmid library DNA and the PCR reaction was per-
formed with 20 cycles.
Sequencing Plasmid Library and RT-PCR Products
Both the RT-PCR products and plasmid library PCR products were
sequenced on either an Illumina HiSeq2000 or Illumina MiSeq with paired
end reads. The forward read crossed the post-splicing exon-exon junction
and the reverse read covered the 30 UTR barcode. A 6-nt index read was
used to sequence the sample barcode to determine if the read came from a
DNA library or a cDNA library.
Associating Degenerate Intronic Regions with 30 UTR Barcode Tags
Using the sequencing results of the DNA plasmid library, we first counted the
number of reads for every observed barcode and calculated an average Phred
quality score for each position. We discarded any barcode tags with less than
two reads or less than an average Phred score of 20 at any position. We then
mapped each remaining tag to the associated degenerate sequence with the
most reads. If each degenerate sequence had a single read, we chose the
sequence with the highest minimum Phred score.
Measuring Isoform Fractions from Sequencing Results
For every read on an RT-PCR product, we recorded the splicing position (or
lack of splicing) by aligning the read to the unspliced plasmid. Using the asso-
ciated barcode read, we were then able to tally the number of reads splicingCell 163, 698–711, October 22, 2015 ª2015 Elsevier Inc. 709
at each position for every plasmid in our library. With respect to the alternative
50 library, only reads that mapped to a splice donor with GT or GC in the +1
to +2 intronic positions were counted.
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